Search Results for ''

published presentations and documents on DocSlides.

The (frequently long,  circuitous, and
The (frequently long, circuitous, and
by jaena
bumpy) trip from clinical problems to clinical tri...
July 2015 PRABHAVATHI FERNANDES, PhD
July 2015 PRABHAVATHI FERNANDES, PhD
by fauna
Founder, President and CEO. How the PATH Act Can R...
What is it like to participate in a clinical trial?
What is it like to participate in a clinical trial?
by samir599
Karen-Sue Carlson, MD, PhD. Associate Professor of...
Phase I Trial Designs Jud Blatchford, PhD
Phase I Trial Designs Jud Blatchford, PhD
by faustina-dinatale
Colorado School of Public Health. January 30. th....
Phase I Trials:   Statistical Design Considerations
Phase I Trials: Statistical Design Considerations
by marina-yarberry
. Hong Li. (Acknowledgement: some slides from R...
Phase II Clinical Trial Austin Goodrich and Laura Peterman
Phase II Clinical Trial Austin Goodrich and Laura Peterman
by della
Outline. Review of a phase I trial. What is a phas...
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
The Trust-TSC Phase 3 Clinical Trial for Seizures in TSC
by willow
Mary Kay Koenig, MD. Associate Vice Chair for Clin...
Phase I Trials:   Statistical Design Considerations
Phase I Trials: Statistical Design Considerations
by natalia-silvester
Phase I Trials: Statistical Design Consideratio...
Adapting for Success: The Genesis of Adaptive Designs
Adapting for Success: The Genesis of Adaptive Designs
by alida-meadow
Andy Grieve. SVP Clinical Trials Methodology, . I...
OMICS
OMICS
by phoebe-click
International . welcomes submissions that are ori...
How to Find and Participate in a GIST clinical trial
How to Find and Participate in a GIST clinical trial
by natalia-silvester
(aka---how to know where to look and who to call)...
The ERP Boot Camp Time-Frequency Analysis
The ERP Boot Camp Time-Frequency Analysis
by lois-ondreau
Assumption: . The timing of the ERP signal is the...
Pamela Harris, M.D. Percy Ivy, M.D
Pamela Harris, M.D. Percy Ivy, M.D
by min-jolicoeur
.. Jeffrey Moscow, M.D.. James A. Zwiebel, M.D.. ...
OMICS  International  welcomes submissions that are original and technically so as to serve both th
OMICS International welcomes submissions that are original and technically so as to serve both th
by briana-ranney
OMICS Journals are poised in excellence by publi...
Advances in Rheumatoid  Arthritis Management
Advances in Rheumatoid Arthritis Management
by sherrill-nordquist
This program will include a discussion . of inves...
End-Points and Rationale for Phase III Trials in HCC: Adjuvant, Intermediate, and Advanced HCC
End-Points and Rationale for Phase III Trials in HCC: Adjuvant, Intermediate, and Advanced HCC
by maniakti
Richard S. Finn, MD. Professor of Clinical Medicin...
State of the Field  Exploring 2015’s Top Ten List for the HIV Prevention Research Field
State of the Field Exploring 2015’s Top Ten List for the HIV Prevention Research Field
by brooke
Manju Chatani, Stacey Hannah, Mitchell Warren. Thu...
Asking a good early phase clinical trial question
Asking a good early phase clinical trial question
by madeline
NINDS Clinical Trials Methodology COURSE 2019. 1. ...
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
Fifteen Cell TherapiesStem Cell Therapies in Phase III Clinical Trial
by genevieve
By Brandy Sargent Editor, Cell Culture Dish www.ce...
Estimating the dose-toxicity curve from completed Phase I studies
Estimating the dose-toxicity curve from completed Phase I studies
by isla
Alexia Iasonos, . Irina Ostrovnaya. Department of ...
State of the Field  Exploring
State of the Field Exploring
by undialto
2015’s Top Ten List for the HIV Prevention Resea...
Phase III Clinical Trials
Phase III Clinical Trials
by morgan
Brad Rechtzigel Kohei Osterloth. "The gold standar...
Price Indexes for Clinical Trial Research: A Feasibility Study
Price Indexes for Clinical Trial Research: A Feasibility Study
by josiah713
A Feasibility Study. SciSIP. PI Conference, Septe...
The  Ataxias : Research in FRDA, SCA,
The Ataxias : Research in FRDA, SCA,
by stefany-barnette
The Ataxias : Research in FRDA, SCA, MSA Susan ...
Enrolling Adolescents into Adult Phase 3 Trials
Enrolling Adolescents into Adult Phase 3 Trials
by yoshiko-marsland
Enrolling Adolescents into Adult Phase 3 Trials C...
Precision Medicine Clinical Trial Designs
Precision Medicine Clinical Trial Designs
by luanne-stotts
2018 . AACR Annual Meeting. April 15, 2018 . Edwa...
Tuberculosis Trials Consortium Study 31
Tuberculosis Trials Consortium Study 31
by stefany-barnette
AIDS Clinical Trials Group A5349. Rifapentine-con...
Chapter 9 – Extinction of Conditioned Behavior
Chapter 9 – Extinction of Conditioned Behavior
by marina-yarberry
Outline . Effects of Extinction Procedures. Decre...
Regulatory  Toxicology Presentation
Regulatory Toxicology Presentation
by marina-yarberry
Overview. Overview. . of. . the. . Food. . an...
Workmanship and Tests  During Construction Phase
Workmanship and Tests During Construction Phase
by debby-jeon
Presented by:. Er. . . Bhagawan. . Shrestha. Spe...
Biomedical research methods
Biomedical research methods
by giovanna-bartolotta
What are biomedical research methods?. An integra...
Basket
Basket
by yoshiko-marsland
Designs . of Phase III . Confirmatory . Trials. C...
Selecting Therapy for Relapsed/
Selecting Therapy for Relapsed/
by tawny-fly
Refractory Multiple Myeloma. Case #1. Monitoring ...
Adaptive Population Enrichment for Oncology Trials with Tim
Adaptive Population Enrichment for Oncology Trials with Tim
by giovanna-bartolotta
Cyrus Mehta, Ph.D.. President, Cytel Inc. .. Stat...
Drug Discovery:
Drug Discovery:
by yoshiko-marsland
an Industrial Process. How are drugs . discovered...
Herbal Drug Regulation
Herbal Drug Regulation
by phoebe-click
02-Jun-2011. What is traditional medicine?. WH...
OMICS International welcomes submissions that are
OMICS International welcomes submissions that are
by myesha-ticknor
OMICS International welcomes submissions that are ...
 The  Ataxias : Research in FRDA, SCA,
The Ataxias : Research in FRDA, SCA,
by aaron
MSA. Susan L. Perlman M.D.. Clinical Professor of...
QST for phase 2 trials Long-term neuropathic and non-neuropathic conditions
QST for phase 2 trials Long-term neuropathic and non-neuropathic conditions
by thomas
Per Hansson, MD, . DMSci. , DDS. Karolinska. . In...